Feb. 06, 2024 -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced data demonstrating treatment with UX111 (ABO-102) AAV gene therapy resulted in rapid and sustained decreased levels of heparan sulfate (HS) in cerebrospinal fluid (CSF) in patients with Sanfilippo syndrome type A (...
Certification, Cleanroom Certification and Aseptic Medicine Compounding Process and Facilities Certification carried by The Lab (Asia). These services aim at safeguarding the operations from biocontamination in both public and private hospitals, overseas pharmaceutical companies and medical equipment ...